NOME
Overview
NOME (Nordic Mentor Network for Entrepreneurship) is an elite, non-profit mentoring program and accelerator for promising life science startups in the Nordics. Founded in 2016 and funded by the Novo Nordisk Foundation, NOME connects startups with world-class mentors, including investors, serial entrepreneurs, and industry executives. The program focuses on mentoring startups in biotech, medtech, diagnostics, healthcare, and digital health to help them become commercial successes. NOME does not take any fees or equity from the startups it supports.
Portfolio Companies
5
Website
nome.nuInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sartar Therapeutics | Oct 2020 | Seed | Co-investor |
| Pharma Holdings | Dec 2022 | VC Round | Co-investor |
| SynuCa Therapeutics | Feb 2025 | Accelerator | Co-investor |
| Aplex Bio | Mar 2022 | Seed | Co-investor |
| NaDeNo Nanoscience | - | Accelerator | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is NOME based?
NOME is headquartered in Copenhagen, Capital Region of Denmark, Denmark.
When was NOME founded?
Founding year information for NOME is not publicly available.
How many portfolio companies does NOME have?
NOME has 5 portfolio companies in Caplight's dataset.
What are some companies in NOME's portfolio?
Portfolio companies visible on Caplight include Sartar Therapeutics, Pharma Holdings, SynuCa Therapeutics, Aplex Bio, NaDeNo Nanoscience.
What was NOME's most recent investment shown here?
NOME's most recent investment in this portfolio sample was in SynuCa Therapeutics in 2025.
What sectors does NOME focus on?
NOME focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does NOME focus on?
NOME typically invests at the Early stage.